Literature DB >> 31513721

The reliability and validity of the Turkish version of the MISSCARE Survey-Patient.

Betül Sönmez1, Öznur İspir1, Buse Türkmen2, Sergül Duygulu3, Aytolan Yıldırım1.   

Abstract

AIM: This methodological study aimed to adapt the MISSCARE Survey-Patient, which evaluates patients' experiences regarding nursing care based on their reports, and to test it for validity and reliability in Turkish.
BACKGROUND: Identifying the missed care interventions on the basis of nurse and patient reports are important to ensure an objective evaluation and develop solutions to the causes behind the failure to meet care needs.
METHODS: The study sample consisted of 267 inpatients in the internal and surgery services in a university hospital (n = 267). The Turkish version of the survey was subjected to language and content validity analyses and to confirmatory factor analysis for construct validity. The reliability of the survey was tested through test-retest method and the Cronbach's alpha internal consistency coefficient.
RESULTS: It was determined that the original construct was preserved in the Turkish version of the MISSCARE Survey-Patient. The findings indicated that the scale was stable and reliable.
CONCLUSION: The Turkish version of the MISSCARE Survey-Patient was found to be valid and reliable. IMPLICATIONS FOR NURSING MANAGEMENT: The survey can be used to determine the frequency and duration of nursing care based on patients' reports and is a valid and reliable instrument for cross-cultural studies.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  adverse events; hospital; missed care; nursing care; patient reported

Mesh:

Year:  2019        PMID: 31513721     DOI: 10.1111/jonm.12865

Source DB:  PubMed          Journal:  J Nurs Manag        ISSN: 0966-0429            Impact factor:   3.325


  1 in total

1.  Missed nursing care before and during the COVID-19 pandemic: A comparative cross-sectional study.

Authors:  Othman A Alfuqaha; Fadwa N Alhalaiqa; Mohammad K Alqurneh; Ahmad Ayed
Journal:  Int Nurs Rev       Date:  2022-08-10       Impact factor: 3.384

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.